TABLE 3.
Antimicrobial resistance profile no. | Antimicrobial resistance patterna | No. of isolates | ST(s)b | Subtype cluster (no. of isolates)c |
---|---|---|---|---|
1 | A | 3 | 1828 (2/3), 2934 (1/3) | A (3) |
2 | AQ | 6 | 2934 (4/4) | A (6) |
3 | AS | 5 | 2132 (5/5) | C (5) |
4 | ASKQ | 1 | ND | B (1) |
5 | AT | 5 | 1839 (1/1) | A (1), B (4) |
6 | ATQ | 4 | 1839 (2/2) | A (1), B (3) |
7 | ATK | 2 | ND | A (1), B (1) |
8 | ATKQ | 10 | 2934 (3/4), 1796 (1/4) | A (9), B (1) |
9 | ATS | 4 | 1839 (1/1) | B (4) |
10 | ATSQ | 17 | 1839 (4/9), 2935 (1/9), 2936 (3/9), 2937 (1/9) | A (1), B (15), C (1) |
11 | ATSK | 8 | 2132 (3/3) | B (2), C (6) |
12 | ATSKQ | 13 | 1839 (4/7), 2132 (2/7), 1162 (1/7) | B (9), C (4) |
13 | T | 2 | 1698 (2/2) | C (2) |
A, ampicillin; K, kanamycin; S, streptomycin; T, tetracycline; Q, (fluoro)quinolone (nalidixic acid and ciprofloxacin).
Data in parentheses represent the number of isolates with the ST out of the total number of isolates. ND, not determined.
Based on fla typing and PFGE profiles (Fig. 1).
For the 13 antimicrobial resistance profiles, there were totals of 13 patterns, 80 isolates, 10 STs, 22 subtype cluster A isolates, 40 subtype cluster B isolates, and 18 subtype cluster C isolates.